Pharmacokinetics of intravitreal bevacizumab (Avastin(®)) in rabbits

PURPOSE: To describe the pharmacokinetics of intravitreal bevacizumab (Avastin(®)) in rabbits. METHODS: The right eye of 20 rabbits was injected intravitreally with 1.25 mg/0.05 mL bevacizumab. Both eyes of four rabbits each time were enucleated at days 1, 3, 8, 15, and 29. Bevacizumab concentration...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Sinapis, Christos I, Routsias, John G, Sinapis, Angelos I, Sinapis, Dimitrios I, Agrogiannis, George D, Pantopoulou, Alkistis, Theocharis, Stamatis E, Baltatzis, Stefanos, Patsouris, Efstratios, Perrea, Despoina
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2011
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3104800/
https://ncbi.nlm.nih.gov/pubmed/21629577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S19555
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller